Moreover, the use of algorithms in hiring and performance evaluation processes can perpetuate systemic biases and discrimination. Algorithms that rely on historical data tend to reflect and perpetuate existing inequalities, leading to biased outcomes in recruitment, promotion, and compensation decisions. This can further exacerbate social inequalities and marginalize certain groups within the workforce.As the entrepreneur embarks on this groundbreaking venture, he faces numerous challenges and obstacles. From navigating regulatory approvals to overcoming cultural barriers and misconceptions about HPV vaccination in men, the road ahead is fraught with difficulties. However, with his determination, resources, and vision, he is well positioned to surmount these challenges and revolutionize the male HPV vaccine market."Manchester United need to be ruthless in their decision-making. If players are not performing to the level required, then they should be shown the door. It's vital for the club to have a strong, cohesive squad that is capable of competing at the highest level," Ferdinand stated.
Accomplished Leader Brings Expertise in Finance and Tribal Governance SAN DIEGO , Dec. 17, 2024 /PRNewswire/ -- Indigenized Energy, a Native-led organization building sustainable solar energy systems with Tribes nationwide, has announced the appointment of Lorilee J. Morsette , MS, THRP as Chief Operating Officer (COO). Morsette previously served as President of National Accounts for Tribal Markets at Mutual of America Financial Group and led HR operations for nearly 600 employees at the Nisqually Indian Tribe in Olympia, Washington . As COO, Morsette will oversee program delivery, finance, human resources, technology, and will ensure operational excellence. The newly created COO role is integral to scaling the organization's impact in 2025 and beyond. In April, Indigenized Energy, along with its partners the MHA Nation-Three Affiliated Tribes and the Tribal Renewal Energy Coalition, were awarded $135.5M in Solar for All funding by the EPA. A Suquamish and Chippewa-Cree from Rocky Boy, Montana , Morsette brings a visionary approach informed by the historical challenges faced by Indian Country. Morsette said, "Joining Indigenized Energy allows me to combine my expertise in financial services with my deep commitment to advancing opportunities for Native Americans. Our community's strength lies in our autonomy, and Indigenized Energy stands as a beacon of hope towards that goal. Together, we are Native-led, driven by our shared values, and contributing to a future where all voices and spirits thrive." Morsette's leadership adds depth to Indigenized Energy's executive team, which already excels in solar technology and tribal relations. Her presence is a milestone for Native women in leadership: women hold only 15% of C-suite roles in the finance sector and 18% in the solar industry, with Native American women representing a fraction of these figures. Cody Two Bears, Founder and CEO of Indigenized Energy said, "If we wrote a COO job description that called for expertise in corporate finance, management, Tribal governance, and values that align seamlessly with our own, and then looked for a Native American woman, we never would have found that. We cast a wider net and fortunately, connected with Lorilee at a time when she was open to a bold new leadership opportunity. Her appointment is a testament to the right timing and shared vision. I have no doubt." About Indigenized Energy With a mission focused on developing innovative and practical energy solutions, Indigenized Energy endeavors to support tribal autonomy, economic development, and environmental stewardship through clean energy initiatives. Indigenized Energy is registered as a charitable corporation in North Dakota and is a fiscally sponsored project of Mission Edge San Diego, a 501(c)(3) nonprofit headquartered in San Diego. Our Federal Tax ID # 27-2938491. https://www.4indigenized.energy/ View original content to download multimedia: https://www.prnewswire.com/news-releases/indigenized-energy-names-lorilee-j-morsette-as-chief-operating-officer-302334331.html SOURCE Indigenized EnergyWalmart just launched a massive after-Christmas sale - here are 27 deals I'd buyPresident-elect Donald Trump proved he’s still a master troll this week with a talking about a US desire to seize the Panama Canal and Greenland and turn Canada into the 51st state. Panama apparently didn’t get the ‘joke’, with President Jose Raul Mulino taking to social media to emphasize that “every square meter” of the canal “belongs to Panama and will continue to belong to Panama.” “We’ll see about that!” Trump retorted. What’s the Canal’s Importance? Accounting for about of all global maritime trade, and (as much as 22 days) off trips between the Pacific and Atlantic Oceans, the Panama Canal has served as a key economic and strategic chokepoint for more than a century, spending most of that time under US control. Crossable by ship in just 8-10 hours, the 81.5 km long, 33-150 m wide mega canal earns Panama about $3.5 billion in transit fees. The canal was opened in 1914 after a decade of US-led, supervised and financed construction - costing the equivalent of over $15 bln in today’s money. The US gained control of the Panama Canal Zone as a concession in 1903 after recognizing Panama’s independence from Colombia, and jealously guarded it until 1999 – when it was transferred back to Panama in accordance with the terms of a 1979 treaty, reached partly thanks US fears of growing Soviet influence in Latin America. The US maintained the right to guard the canal in perpetuity. The canal has proven on global shipping that it led to the creation of its own class of massive bulk carriers – known as the Panamax – featuring a deadweight capacity of 60,000-80,000 tons. Whether he's joking or not, Trump isn’t the first Republican to criticize the 1979 treaty, with doing so on the campaign trail in 1976 and 1980, but dropping the idea soon after actually entering office. 05:25 GMT Could Trump Really Be Serious? Trump “was just making a joke” and there is no legal way for US to actually restore its control over the Panama Canal, veteran geopolitical affairs and trade policy expert Thomas Pauken II told Sputnik. Besides highlighting the “overreaction” to his gag by media and senior officials, Trump’s discussion of the canal is really designed to address the reported overcharging of US shippers, with his hardball threats aimed at seeing “those rates go down,” and addressing whether the US’s trade competitors, particularly China, are receiving any preferential treatment, Pauken said. “It's really a simple case of wanting to negotiate lower rates on shipping charges and then making a joke about how America may supposedly try to seize control of the Panama Control Canal and take charge of it. Of course, everybody who has any common sense, including people who are supposedly diplomats, media officials and even law experts, should know that Trump cannot take control of the Panama Canal if Panama refuses to allow that,” the observer stressed. The canal could become a hotspot for confrontation between China and the US, Pauken believes, but only “if Beijing and Washington choose to start and launch and spark trade wars” instead of sitting down and hammering out a “grand bargain” that both sides would find fair – like the Phase One Trade Agreement reached in late 2019. 05:05 GMT
Biotech stocks, particularly in the small- and mid-cap space, were hot topics among retail investors in 2024, often spurred by major announcements or clinical developments. Collectively, these stocks attracted significant chatter on Stocktwits. Here are the top five biotech stocks with the highest message volume growth this year: Tonix Pharmaceuticals Holding Corp. (TNXP) : +47,066% Message Volume Tonix focuses on developing therapies to treat and prevent diseases. Its TNX-102 SL, a non-opioid analgesic for fibromyalgia, gained attention when the FDA accepted its New Drug Application in December. Earlier in the year, the company also reiterated its commitment to developing an mpox vaccine. Despite these milestones, TNXP shares are down over 97% this year. Candel Therapeutics Inc. (CADL) : +16,000% Message Volume Candel develops viral immunotherapies targeting cancer. Its lead product, CAN-2409, is under trial for various cancers, including prostate and non-small cell lung cancer. Positive late-stage results released this month for CAN-2409 in prostate cancer drove retail interest. Shares of CADL are up over 500% this year. Cardio Diagnostics Holdings Inc. (CDIO) : +11,650% Message Volume Cardio Diagnostics gained traction with its AI-powered PrecisionCHD test for coronary heart disease. The test demonstrated significant cost-saving potential in healthcare, according to the company. Cardio also received final pricing determinations from the Centers for Medicare & Medicaid Services for its products. Its stock has fallen nearly 63% year-to-date. Recursion Pharmaceuticals Inc. (RXRX) : +9,600% Message Volume Recursion uses AI and automation to discover medicines. A $50 million investment from Nvidia to support AI-driven drug discovery efforts primarily sparked significant retail interest this year, although RXRX shares have declined 22% so far in 2024. Galectin Therapeutics Inc. (GALT) : +5,800% Message Volume Galectin’s focus on fibrotic and inflammatory diseases, led by its drug belapectin, caught investors’ attention despite mixed trial results. While the drug didn’t meet statistical significance for a key endpoint in an early liver disease trial, further data analysis is expected in early 2025. GALT shares are down over 48% this year. For updates and corrections, email newsroom[at]stocktwits[dot]com.<
Biotech stocks, particularly in the small- and mid-cap space, were hot topics among retail investors in 2024, often spurred by major announcements or clinical developments. Collectively, these stocks attracted significant chatter on Stocktwits. Here are the top five biotech stocks with the highest message volume growth this year: Tonix Pharmaceuticals Holding Corp. (TNXP) : +47,066% Message Volume Tonix focuses on developing therapies to treat and prevent diseases. Its TNX-102 SL, a non-opioid analgesic for fibromyalgia, gained attention when the FDA accepted its New Drug Application in December. Earlier in the year, the company also reiterated its commitment to developing an mpox vaccine. Despite these milestones, TNXP shares are down over 97% this year. Candel Therapeutics Inc. (CADL) : +16,000% Message Volume Candel develops viral immunotherapies targeting cancer. Its lead product, CAN-2409, is under trial for various cancers, including prostate and non-small cell lung cancer. Positive late-stage results released this month for CAN-2409 in prostate cancer drove retail interest. Shares of CADL are up over 500% this year. Cardio Diagnostics Holdings Inc. (CDIO) : +11,650% Message Volume Cardio Diagnostics gained traction with its AI-powered PrecisionCHD test for coronary heart disease. The test demonstrated significant cost-saving potential in healthcare, according to the company. Cardio also received final pricing determinations from the Centers for Medicare & Medicaid Services for its products. Its stock has fallen nearly 63% year-to-date. Recursion Pharmaceuticals Inc. (RXRX) : +9,600% Message Volume Recursion uses AI and automation to discover medicines. A $50 million investment from Nvidia to support AI-driven drug discovery efforts primarily sparked significant retail interest this year, although RXRX shares have declined 22% so far in 2024. Galectin Therapeutics Inc. (GALT) : +5,800% Message Volume Galectin’s focus on fibrotic and inflammatory diseases, led by its drug belapectin, caught investors’ attention despite mixed trial results. While the drug didn’t meet statistical significance for a key endpoint in an early liver disease trial, further data analysis is expected in early 2025. GALT shares are down over 48% this year. For updates and corrections, email newsroom[at]stocktwits[dot]com.<
The incident serves as a reminder of the critical importance of robust disaster recovery and contingency planning in data center operations. Companies that rely on cloud services must have measures in place to mitigate risks and ensure the continuity of their business operations in the event of unforeseen incidents.McLean, Duax lead FGCU over Florida International 60-59
However, one individual who seems to be reveling in Macron's struggles is none other than Song Zhongping, a military expert and commentator from China. Song, known for his sharp analysis and provocative comments, has not shied away from expressing his views on Macron's leadership woes. In a recent interview, he pointed out that Macron's government is akin to a "lame duck" or a "lame duck" due to its inability to effectively address the various challenges facing France.
One of the key pillars of economic management is the implementation of effective financial policies that align with market expectations. By carefully calibrating fiscal measures such as tax adjustments, government spending, and public investment, authorities can steer the economy towards a path of balanced growth and resilience. Additionally, maintaining transparent communication with market participants and stakeholders is vital in ensuring predictability and reducing uncertainties.The US says it pushed retraction of a famine warning for north Gaza. Aid groups express concern.
What Biden and Senate Democrats Can Do Now to Stop TrumpIn recent years, French President Emmanuel Macron has found himself facing numerous challenges both domestically and internationally. The ongoing protests by the Yellow Vest movement, economic slowdown, and now the COVID-19 pandemic have all contributed to Macron's dwindling popularity and a sense of discontent among the French population. Against this backdrop, political analysts have started to label Macron's government as a "lame duck" or a "lame duck" in Chinese, indicating a government that is weak, ineffective, and struggling to maintain control.